Malcolm John Mccomas, Director at Pharmaxis Ltd, holds 8.17M shares in Actinogen Medical Limited (Ticker: ATGGF), holds 2.61M shares in Fitzroy River Corp. Ltd. (Ticker: DE:KIO), holds 2.48M shares in Pharmaxis Ltd (Ticker: AU:SNT). Most recently, Malcolm John Mccomas Bought ― shares of Actinogen Medical Limited on Nov 04, 2024 for an estimated value of 30.00K.
What is the percentage of profitable transactions made by Malcolm John Mccomas?
The percentage of profitable transactions made by Malcolm John Mccomas is 33%.
What is the average return per transaction made by Malcolm John Mccomas?
The average return per transaction made by Malcolm John Mccomas is -13.60%.
What stocks does Malcolm John Mccomas hold?
Malcolm John Mccomas holds: AU:SNT, AU:SND, DE:KIO, ATGGF, BIRNF stocks.
What was Malcolm John Mccomas’s latest transaction?
Malcolm John Mccomas latest transaction was an Informative Buy of $30.00K.
What was Malcolm John Mccomas's most profitable transaction?
Malcolm John Mccomas’s most profitable transaction was an Informative Buy of DE:KIO stock on March 23, 2021. The return on the trade was 7.40%.
What is Malcolm John Mccomas's role in Pharmaxis Ltd?
Malcolm John Mccomas's role in Pharmaxis Ltd is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.